INVESTOR OVERVIEW

NYSE: USNA

November 2021

SAFE HARBOR

Forward-Looking Statements.

This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including: uncertainty related to the magnitude, scope and duration of the impact of the COVID-19 pandemic ("COVID-19") to our business, operations and financial results; the further spread of, and regulatory measures or voluntary actions that may be put in place to limit the spread of, COVID-19 in the markets where we operate, including restrictions on business operations, shelter at home, or social distancing requirements; the potential for a resurgence of COVID-19 spread in any of our markets in the future; the impact of COVID-19 on the domestic and world economies, including any negative impact on discretionary spending, consumer demand, and consumer behavior in general; regulatory risk in China in connection with the health products and direct selling business models; regulatory risk in the United States in connection with the direct selling business model; potential negative effects of deteriorating foreign and/or trade relations between the United States and China; potential negative effects of material breaches of our information technology systems to the extent we experience a material breach; material failures of our information technology systems; global economic conditions generally; reliance upon our network of independent Associates; risk associated with governmental regulation of our products, manufacturing and direct selling business model; adverse publicity risks globally; risks associated with our international expansion and operations; and uncertainty relating to the fluctuation in U.S. and other international currencies. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission. The forward- looking statements in this presentation set forth our beliefs as of the date hereof. We do not undertake any obligation to update any forward-looking statement after the date hereof or to conform such statements to actual results or changes in the Company's expectations, except as required by law.

Non-GAAP Financial Measures.

The Company prepares its financial statements using U.S. generally accepted accounting principles ("GAAP"). Constant currency net sales, earnings, EPS and other currency-related financial information (collectively, "Financial Results") are non-GAAP financial measures that remove the impact of fluctuations in foreign-currency exchange rates ("FX") and help facilitate period-to-period comparisons of the Company's Financial Results that we believe provide investors an additional perspective on trends and underlying business results. Constant currency Financial Results are calculated by translating the current period's Financial Results at the same average exchange rates in effect during the applicable prior year period and then comparing this amount to the prior-year period's Financial Results. Free cash flow ("FCF") is a non-GAAP financial measure that we believe provides investors an additional perspective on cash flow from operating activities in excess of amounts required for reinvestment. We believe it provides a measure of our ability to fund various discretionary business initiatives, including acquisitions and share repurchase. Free cash flow is calculated by subtracting net capital expenditures from net cash provided by operating activities. Return on invested capital ("ROIC") is a non-GAAP financial measure that we believe provides a measure of how effectively we deploy our capital base. We calculate ROIC as net operating profit after-tax for the trailing twelve

months divided by average total debt and shareholders' equity for the trailing twelve months.

USANA At-A-Glance

USANA develops and manufactures high-quality, science based nutritional and personal care products with a primary focus on promoting long-term health and wellness.

Headquarters:

Salt Lake City, UT

Founded:

1992

Employees:

1,943

Annual Revenue: $1.1B¹

Market Cap: $2.0B²

  • FY 2020

Product Mix¹

Nutritionals

85%

All Other

1%

Foods

7%

Skincare 7%

Geographic Mix¹

North Asia 10%

Americas &

Europe

19%

Greater China

47%

Southeast

Asia Pacific

24%

² As of 11/9/21

Stable and Solid Long-Term Performance

Sales

Diluted EPS

Free Cash Flow

$6.55

$133

$1,230

$1,006

$104

$3.99

2016

TTM Q3 2021

2016

TTM Q3 2021

2016

TTM Q3 2021

$Millions

$Millions

OUR OPERATIONAL PROCESS

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

USANA Health Sciences Inc. published this content on 09 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 November 2021 23:24:04 UTC.